Multiple reputable sources, including Reuters and CNBC, report that Akeso's experimental lung cancer drug, ivonescimab, has demonstrated significant efficacy in a late-stage clinical trial in China. The drug improved overall survival for lung cancer patients, reducing the risk of death by 34% and extending patient lifespans by 15% compared to a leading immunotherapy. These results, presented at a major oncology meeting, are supported by consistent trial data across several outlets, indicating a potentially important advancement in the treatment of lung cancer. The findings highlight the ongoing progress in oncology drug development and the potential for new therapies to outperform existing standards of care.
In addition to Akeso's breakthrough, Johnson & Johnson's prostate cancer drug Erleada has also shown promising results in a late-stage trial. When used in combination with hormone-blocking therapy before and after surgery, Erleada reduced the risk of cancer spread and death, according to data presented at a medical conference. Multiple mainstream sources confirm the consistency of these trial endpoints, underscoring the drug's potential to improve outcomes for prostate cancer patients. These developments reflect a broader trend of innovation and progress in cancer therapeutics, offering hope for improved survival rates and quality of life for patients facing serious diagnoses.
Meanwhile, the S&P 500 dividend yield has dropped to 1.08%, marking the lowest payout rate since the 1800s. This historic low, corroborated by 24/7 Wall Street and supported by historical financial data, signals a shift in the income landscape for equity investors. As companies prioritize growth and share buybacks over dividend distributions, investors seeking yield may need to reassess their strategies or look to alternative asset classes to meet their income needs in the current market environment.
🔹
Justification: The news highlights major breakthroughs in oncology drug development, with both Akeso and Johnson & Johnson reporting strong, late-stage clinical trial results for cancer therapies. These advances are likely to boost sentiment in the healthcare and biotech sectors, reflecting significant progress and potential for improved patient outcomes. However, the historic drop in the S&P 500 dividend yield introduces a mild negative for income-focused investors, signaling a shift in market dynamics. On balance, the positive impact from medical innovation outweighs the negative implications of lower dividends, resulting in a mild positive overall market impact.
Legend:
🔴 = Strong Negative Impact 🔸 = Mild Negative Impact ⚪ = Neutral 🔹 = Mild Positive Impact 🔵 = Strong Positive Impact
Memo on US president's health released after physical earlier in the week; leg swelling continues but has improved, memo says; Trump turns 80 in June...
The Times of Israel - 5/31/2026 1:55:32 AM
More News for
Stock Analysis for
Related Stocks:
Summer is often a slow time on Wall Street, as investors take time off for family and vacations. If you are planning some summer fun, here's a simple formula for generating dividends that requires little attention....
The Motley Fool - 5/31/2026 9:15:00 AM
More News for DIVO
Stock Analysis for DIVO
Related Stocks:
RYBREVANT FASPRO⢠(amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where...
GuruFocus - 5/31/2026 9:00:00 AM
More News for JNJ
Stock Analysis for JNJ
Related Stocks:
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri Test Substantially Increased Cancer Detection With R...
GuruFocus - 5/31/2026 9:00:00 AM
More News for GRAL
Stock Analysis for GRAL
Related Stocks:
Johnson and Johnson's Phase 3 prostate cancer study shows ERLEADAÂ (apalutamide) before and after surgery significantly reduces risk of metastas...
GuruFocus - 5/31/2026 9:00:00 AM
More News for APA
Stock Analysis for APA
Related Stocks:
Welcome to The Muni Brief, a series on municipal credit and markets. In each installment, Senior Municipal Strategist James Colby examines current events, policy developments, and fiscal trends through the lens of the muni investor — covering topics both local and national....
ETF Trends - 5/31/2026 9:36:59 AM
More News for NYC
Stock Analysis for NYC
Related Stocks:
A Love Island USA cast member has been dismissed from the reality dating show just days ahead of its eighth season premiere following resurfaced videos in which the contestant used a racial slur. Vasa......
Yahoo - 5/31/2026 12:22:00 AM
More News for
Stock Analysis for
Related Stocks:
Silicom Ltd. is rated buy, trading at a steep 2.36x NTM revenue versus a 9.51x peer median, despite five quarters of sequential growth. SILC's design-win model, R&D intensity, and expanding edge/security use cases drive recurring revenue and create structural switching costs. Three macro tailwinds—AI inference, post-quantum cryptography, and white-label switches—support a bottom-line recovery and offer material upside optionality....
Seeking Alpha - 5/31/2026 9:25:55 AM
More News for SILC
Stock Analysis for SILC
Related Stocks:
The president had earlier said on social media that he should take the place of “these highly paid, Third Rate ‘Artists,’” saying he gets “larger audiences than Elvis.”...
The New York Times - 5/31/2026 1:14:45 AM
More News for
Stock Analysis for
Related Stocks:
Repligen Has A Cleaner Recovery Angle, But With High Valuation...
Seeking Alpha - 5/31/2026 9:15:00 AM
More News for RGEN
Stock Analysis for RGEN
Related Stocks:
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced positive overall survival (OS) results from the Phase III HARMONi-6 trial, conducted in China and sponsored by Summit's partner Akeso, Inc. (HKEX Code: 9926.HK), will be presented today as part of the Plenary Session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The presentation is entitled “Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in previously untrea....
Business Wire - 5/31/2026 9:06:00 AM
More News for SMMT
Stock Analysis for SMMT
Related Stocks:
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancer In head and neck cancer, IMA401 treatment at recommended Phase 2 dose (RP2D) with or without pembrolizumab resulted in a 29% confirmed ORR (4/14), 64% DCR (9/14) and mDOR of 8....
Globe News Wire - 5/31/2026 9:00:00 AM
More News for IMTX
Stock Analysis for IMTX
Related Stocks:
The Moment Many Retirees Don't See Coming A 70-year-old living on $30,000 in Social Security has been getting by on a tight budget for years. The car needs replacing, the roof is leaking, and the traditional IRA has been sitting there untouched. Pulling out $50,000 to cover the year's big expenses feels reasonable. Then the... The Hidden Cost of Large IRA Withdrawals: How $50,000 Can Cost You $6,200 in Taxes...
247 Wallst - 5/31/2026 8:45:27 AM
More News for
Stock Analysis for
Related Stocks:
The SpaceX IPO is putting the focus on the massive opportunity in space, and these two stocks stand to benefit....
Fool - Investing News - 5/31/2026 8:45:00 AM
More News for ASTS
Stock Analysis for ASTS
Related Stocks:
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of New Era Energy & Digital, Inc. (NASDAQ: NUAI) between November 6, 2024 and December 29, 2025, inclusive (the "Class Period"), of the important June 1, 2026 lead plaintiff deadline. SO WHAT: If you purchased New Era Energy securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
Newsfile Corp - 5/31/2026 9:11:00 AM
More News for NUAI
Stock Analysis for NUAI
Related Stocks:
ePlus inc. ended FY2026 on a strong note. Fourth quarter revenues grew well, which ePlus managed to turn into increased earnings. AI seems to be a tailwind on PLUS's growth going forward, as customers are investing in AI capabilities. There's reason to be cautious. PLUS's FY2026 growth seems to have been achieved due to a few outsized projects, which may not be replicated....
Seeking Alpha - 5/31/2026 9:08:22 AM
More News for PLUS
Stock Analysis for PLUS
Related Stocks:
Vicor: Mid-Quarter Guidance Raise Confirms The IP Thesis (Rating Upgrade)...
Seeking Alpha - 5/31/2026 9:06:00 AM
More News for VICR
Stock Analysis for VICR
Related Stocks:
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Immutep To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Immutep between March 24, 2025 and March 12, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - May 31, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP) and reminds investors of the July 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....
Newsfile Corp - 5/31/2026 9:04:00 AM
More News for IMMP
Stock Analysis for IMMP
Related Stocks:
Amplify CWP Growth & Income ETF delivers a double-digit yield and equity appreciation, outperforming SPY since inception with a 44.68% total return. QDVO's tactical covered call strategy on a concentrated large-cap growth portfolio enables participation in rallies while generating recurring income. Technology exposure exceeds 40%, with the Magnificent Seven comprising 64% of assets, targeting both high option premiums and growth....
Seeking Alpha - 5/31/2026 9:00:00 AM
More News for QDVO
Stock Analysis for QDVO
Related Stocks:
A loud noise caused by a meteor was heard throughout Rhode Island and Massachusetts at around 2:10 on Saturday afternoon....
WJAR - 5/31/2026 12:56:17 AM
More News for
Stock Analysis for
Related Stocks:
Microsoft offers significant upside, with robust growth drivers from AI partnerships and cloud expansion, making current valuations highly attractive. Partnership with Anthropic could generate up to $43 billion in annual revenue by 2030, boosting MSFT's AI and cloud prospects. Accelerated AI data center deployment and Copilot's shift to usage-based pricing are set to drive recurring revenue and margin expansion for MSFT....
Seeking Alpha - 5/31/2026 9:00:00 AM
More News for MSFT
Stock Analysis for MSFT
Related Stocks:
BitFuFu is downgraded to Hold after Q1 FY26 results reveal persistent tight margins. FUFU's dual-engine model hedges revenue volatility, with cloud mining now 79% of revenue, but cost structure remains burdened by related-party hosting fees. Operational efficiency improved: hashrate under management rose 25.7% YoY while power capacity fell, yet gross margin stayed minimal at 0.51%....
Seeking Alpha - 5/31/2026 9:00:00 AM
More News for FUFU
Stock Analysis for FUFU
Related Stocks:
Intellia Therapeutics remains a Buy, driven by two pivotal in vivo gene therapy catalysts: Lonvo-Z for HAE and Nex-Z for ATTR amyloidosis. Lonvo-Z's Phase 3 data met all endpoints with an 87% attack reduction, but market reaction was muted due to safety concerns and the competitive landscape. The FDA lifted clinical holds on Nex-Z Phase 3 trials, enabling advancement in a $16.8bn ATTR market with a differentiated one-time treatment profile....
Seeking Alpha - 5/31/2026 8:45:00 AM
More News for NTLA
Stock Analysis for NTLA
Related Stocks:
The iShares Core S&P U.S. Value ETF offers broad, diversified exposure to U.S. value equities with a low 0.04% expense ratio. IUSV's long-term returns and volatility closely match the Russell 1000 benchmark, but recent performance lags, with a 6% shortfall over the past year. Competitors VLUE and FVAL have outperformed IUSV since 2016, aided by cash-flow-based valuation and sector-specific methodologies....
Seeking Alpha - 5/31/2026 8:37:59 AM
More News for IUSV
Stock Analysis for IUSV
Related Stocks:
Believe it or not, June is here, and with it the summer trading season. That means lower trading volumes, potential for volatility, and opportunities for savvy traders....
MarketBeat - 5/31/2026 8:36:20 AM
More News for AIRJ
Stock Analysis for AIRJ
Related Stocks:
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of DNOW Inc. (NYSE: DNOW) resulting from allegations that DNOW may have issued materially misleading business information to the investing public. SO WHAT: If you purchased DNOW securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
Newsfile Corp - 5/31/2026 8:32:00 AM
More News for DNOW
Stock Analysis for DNOW
Related Stocks:
Hormel Foods Corporation reported positive Q2 results. Input cost inflation has weighed on HRL's margins, but retail segment earnings are finally stabilized in the report. A stabilizing earnings outlook makes HRL's dividend yield safer and more attractive....
Seeking Alpha - 5/31/2026 8:30:00 AM
More News for HRL
Stock Analysis for HRL
Related Stocks:
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the next-generation of Lens, its pioneering agentic AI platform designed to accelerate drug development and research. This evolution seamlessly connects Tempus' multimodal data, AI tooling and computational infrastructure to deliver actionable insights at the pace required for drug development. The next-generation of the Lens platf....
Business Wire - 5/31/2026 8:30:00 AM
More News for TEM
Stock Analysis for TEM
Related Stocks:
Japan's Softbank is planning to invest 45 billion euros ($53 billion) over five years to build AI infrastructure in France in the first phase of its push. The commitment is part of a 75-billion-euro ($87 billion) program by Softbank to build AI data centers in France...
CNBC - 5/31/2026 8:09:54 AM
More News for SOBKY
Stock Analysis for SOBKY
Related Stocks:
Sandisk and Micron are both memory chip producers. Both companies are seeing rapid growth....
The Motley Fool - 5/31/2026 8:08:00 AM
More News for MU
Stock Analysis for MU
Related Stocks:
The wife of Maine Democratic Senate candidate Graham Platner said she was “deeply hurt” after details of her husband’s extramarital sexting became public Saturday, accusing a former campaign official and confidante of betraying her trust....
CNN - 5/31/2026 12:28:00 AM
More News for
Stock Analysis for
Related Stocks:
The S&P 500 dividend yield has fallen to 1.08%, a level the index has not seen since the 1800s....
24/7 Wall Street - 5/31/2026 8:26:47 AM
More News for SPY
Stock Analysis for SPY
Related Stocks:
Officials in Longview, Washington, said Saturday afternoon that all nine workers who were missing after a white liquor tank implosion at a paper mill....
KATU - 5/31/2026 12:11:03 AM
More News for
Stock Analysis for
Related Stocks:
My parents have one credit card
and they only use it for one thing. Here's what that's cost them, and the one additional card that could save them a ton....
Fool - Investing News - 5/31/2026 8:05:03 AM
More News for
Stock Analysis for
Related Stocks:
Your age affects how much you have saved for retirement. See where you stand relative to the typical Gen Xer....
Fool - Investing News - 5/31/2026 7:50:00 AM
More News for
Stock Analysis for
Related Stocks:
The S&P 500 is up nearly 10% year to date....
Fool - Investing News - 5/31/2026 7:44:00 AM
More News for
Stock Analysis for
Related Stocks:
That slump won't be instantly reversed, but SoundHound AI still has long-term potential....
Fool - Investing News - 5/31/2026 7:33:00 AM
More News for SOUN
Stock Analysis for SOUN
Related Stocks:
An experimental drug developed by China-based Akeso helped patients with advanced squamous non-small cell lung cancer live 15% longer than BeOne Medicines' immunotherapy Tevimbra, and cut the risk of death by more than one-third in a study presented at a medical meeting on Sunday....
Reuters - 5/31/2026 8:03:54 AM
More News for AKESF
Stock Analysis for AKESF
Related Stocks:
Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the cancer and reduced the risk of disease progression or death, according to data from a late-stage trial presented on Sunday....
Reuters - 5/31/2026 8:01:58 AM
More News for JNJ
Stock Analysis for JNJ
Related Stocks:
Poland has become one of Europe's standout growth stories, with an economy that crossed $1 trillion and a new generation of entrepreneurs returning home after studying and working abroad. Finance Minister Andrzej Domański points to decades of reform, EU integration, foreign investment and a diversified economy as drivers of Poland's rise, while venture capitalist Aleksandra Pedraszewska says Warsaw's technology scene now offers opportunities that were far less obvious a decade ago....
Bloomberg Markets and Finance - 5/31/2026 8:00:12 AM
More News for EPOL
Stock Analysis for EPOL
Related Stocks:
The governor said most of those arrested in a weekend clash were from outside New Jersey....
Gothamist - 5/31/2026 12:03:00 AM
More News for
Stock Analysis for
Related Stocks:
An experimental lung cancer drug from Akeso and Summit Therapeutics improved survival in the Harmoni-6 Phase 3 trial conducted in China, according to results being presented at the American Society of Clinical Oncology annual meeting. Called ivonescimab, the bispecific antibody targets PD-1 — similar to Merck's best-selling drug Keytruda — and VEGF — similar to Roche's Avastin....
CNBC - 5/31/2026 8:00:02 AM
More News for SMMT
Stock Analysis for SMMT
Related Stocks:
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and FOLFIRI (fluorouracil, leucovorin, and irinotecan) versus FOLFIRI with or without bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. These results will be....
Business Wire - 5/31/2026 8:00:00 AM
More News for PFE
Stock Analysis for PFE
Related Stocks:
I focus on HALO investing: Heavy Assets, Low Obsolescence - owning irreplaceable physical assets with durable moats against technological disruption. Top recommendations include American Tower, Brookfield Infrastructure, Prologis, Rexford Industrial, Lineage, Americold, VICI Properties, and Lamar Advertising. AMT, COLD, and VICI currently offer attractive entry points based on discounted multiples, robust dividend yields, and resilient, monopoly-like asset bases....
Seeking Alpha - 5/31/2026 8:00:00 AM
More News for HALO
Stock Analysis for HALO
Related Stocks:
Marsh & McLennan is delivering robust organic revenue growth, strong EPS beats and maintains a compelling dividend profile amid sector headwinds. MRSH trades at a forward P/E of 14.9, well below its 10-year average of 21.9, presenting a 26% discount to fair value. With an A- S&P rating, MRSH is positioned for continued bolt-on acquisitions and sustained dividend growth, targeting at least 9% annual increases....
Seeking Alpha - 5/31/2026 8:00:00 AM
More News for MRSH
Stock Analysis for MRSH
Related Stocks:
VICI Properties has stable cash flows, disciplined growth, and an undervalued 9.6x forward P/FFO multiple. VICI's 100% triple-net lease structure, 100% occupancy, and strong tenant guarantees underpin resilient income and a well-covered 6.4% dividend yield. Recent accretive acquisitions and self-funded investments drive 4.5% AFFO/share growth, supported by a conservative 5.0x net debt/EBITDA balance sheet....
Seeking Alpha - 5/31/2026 8:00:00 AM
More News for VICI
Stock Analysis for VICI
Related Stocks:
Discussions among a group of lawyers with allegiance to the president were closely held. Some senior White House officials were said to have felt blindsided as the agreement took shape....
The New York Times - 5/30/2026 11:47:18 PM
More News for
Stock Analysis for
Related Stocks:
Just when the Giants thought they were out of the Jaxson Dart-Donald Trump conundrum, Trump pulled them back in....
NBC Sports - 5/30/2026 11:40:44 PM
More News for
Stock Analysis for
Related Stocks:
Palo Alto Networks is set to report its latest quarterly earnings after the closing bell Tuesday, with traders expecting a sizable move in the cybersecurity stock that could push it to new highs....
Investopedia - 5/31/2026 7:50:47 AM
More News for PANW
Stock Analysis for PANW
Related Stocks:
Light rail is finally cooking in the Seattle area. It coincides with an existential crisis over building expansion lines for the future. At what point do we say "it's good,"......
The Seattle Times - 5/30/2026 11:28:48 PM
More News for
Stock Analysis for
Related Stocks:
Energy remains a top investment focus due to global demand, constrained supply growth, and attractive sector valuations versus the S&P 500. I highlight my preferred picks across the energy supply chain: LandBridge, Viper Energy, Helmerich & Payne, Diamondback Energy, Western Midstream, and Marathon Petroleum. VNOM offers high cash returns to shareholders, while WES and MPC provide strong yields and capital return strategies, each excelling in their respective niches....
Seeking Alpha - 5/31/2026 7:30:00 AM
More News for VNOM
Stock Analysis for VNOM
Related Stocks:
Schwab US Large-Cap Growth ETF offers low-cost, tax-efficient exposure to leading growth companies, with a strong tilt toward technology and AI leaders. SCHG's top holdings—NVDA, AAPL, and MSFT—anchor its portfolio, benefiting from robust AI adoption and projected double-digit growth rates. Despite trading near 52-week highs and short-term valuation risks, SCHG remains a buy for long-term investors seeking growth at minimal cost....
Seeking Alpha - 5/31/2026 7:30:00 AM
More News for SCHG
Stock Analysis for SCHG
Related Stocks:
Novartis said on Sunday that early data from its experimental actinium-based drug showed signs of anti-tumour activity against prostate cancer, including in patients previously treated with its older drug Pluvicto....
Reuters - 5/31/2026 7:16:57 AM
More News for NVS
Stock Analysis for NVS
Related Stocks:
Jensen Huang has spent the past year repeating one number that keeps growing louder: humanoid robots represent a $40 trillion total addressable market for labor automation....
24/7 Wall Street - 5/31/2026 7:20:57 AM
More News for NVDA
Stock Analysis for NVDA
Related Stocks:
The SPDR S&P Regional Banking ETF (NYSEARCA:KRE | KRE Price Prediction) has quietly become one of 2026's better-performing financial trades, rising roughly 9% year to date and 28% over the past year to around $70 a share....
24/7 Wall Street - 5/31/2026 7:18:33 AM
More News for KRE
Stock Analysis for KRE
Related Stocks:
A double balance transfer, using two balance transfer cards back to back, could get you 42 months of 0% interest
theoretically. Here's what to know....
Fool - Investing News - 5/31/2026 7:10:37 AM
More News for
Stock Analysis for
Related Stocks:
Apple's AI-driven "agentic smartphone" narrative, stock surge, and Nvidia CEO's advisory role highlight major shifts in tech leadership....
Benzinga - 5/31/2026 7:01:02 AM
More News for
Stock Analysis for
Related Stocks:
A 65-year-old retiree walks into a meeting with $600,000 in an IRA and walks out with a pitch. Hand it over to an insurance company today, and a single-premium immediate annuity (SPIA) will pay $3,700 a month for life. That is $44,400 a year, guaranteed, with no market risk and no decisions to make ever... A $600,000 Annuity Pays $3,700 a Month for Life. What About Your Spouse?...
247 Wallst - 5/31/2026 6:52:26 AM
More News for
Stock Analysis for
Related Stocks:
The oil market is approaching a danger zone....
Fool - Investing News - 5/31/2026 6:45:00 AM
More News for XOM
Stock Analysis for XOM
Related Stocks:
Not paying attention could lead to an unwanted surprise....
Fool - Investing News - 5/31/2026 6:36:00 AM
More News for
Stock Analysis for
Related Stocks:
Two weeks after her 52-year-old husband died unexpectedly, a 54-year-old woman called Suze Orman's podcast with the question hundreds of recent widows wrestle with every month: what do I do with the life insurance check? In her case, the payout sat alongside a 401(k) and an IRA, and she wanted to know whether to invest... How $500,000 in Life Insurance Can Earn $18,000 to $19,000 Annually While You Grieve and Decide...
247 Wallst - 5/31/2026 6:30:34 AM
More News for
Stock Analysis for
Related Stocks:
Berkshire uses dividends to fund further investments, which supercharges its returns....
Fool - Investing News - 5/31/2026 6:30:00 AM
More News for AAPL
Stock Analysis for AAPL
Related Stocks:
When a Comfortable Dividend Stream Turns Into a Tax Surprise Picture a single retiree drawing $30,000 a year in Social Security and another $50,000 from a taxable brokerage account stuffed with dividend payers. On paper, it looks like a clean $80,000 retirement: steady, diversified, mostly passive. Then the first full tax return after building that... Social Security Gets Taxed When Dividends Cross This Threshold. Most Retirees Miss It...
247 Wallst - 5/31/2026 6:20:51 AM
More News for
Stock Analysis for
Related Stocks:
Dell Technologies reported a robust Q1'27 beat, driven by strong AI-optimized and traditional server demand and commercial client growth. AI-optimized server backlog surged to $51.3B, and commercial client compute grew 18% YoY, supporting expectations for continued growth and margin improvement. I am reiterating my Buy rating on DELL and raising the price target to $482/share, reflecting confidence in sustained operational momentum....
Seeking Alpha - 5/31/2026 7:06:23 AM
More News for DELL
Stock Analysis for DELL
Related Stocks:
The Procure Space ETF has surged 163% over the past 12 months, driven by sector momentum and anticipation of the SpaceX IPO. UFO's portfolio is concentrated but includes holdings like Sirius XM and Trimble which may not fully capture the speculative upside from the SpaceX catalyst. Some other sector ETFs offer more direct exposure to pureplay space companies and even SpaceX itself....
Seeking Alpha - 5/31/2026 7:00:00 AM
More News for UFO
Stock Analysis for UFO
Related Stocks:
Frankie Valli, whose legendary falsetto defines the sound of the 1960s rock group the Four Seasons, has cancelled the remainder of the band’s 2026 tour dates...
ABC News - Breaking News, Latest News and Videos - 5/30/2026 10:54:55 PM
More News for
Stock Analysis for
Related Stocks:
Amy Gertner, wife of Democratic Senate candidate in Maine, says she is ‘hurt’ ex-political director exposed texts...
The Guardian - 5/30/2026 10:49:00 PM
More News for
Stock Analysis for
Related Stocks:
Darren Till survived an early scare and then delivered a brutal knockout in his bare-knuckle debut....
MMA Fighting - 5/30/2026 10:38:50 PM
More News for
Stock Analysis for
Related Stocks:
Tracking generative AI as a daily beat means watching dozens of funds slap the “AI” label on portfolios that look suspiciously like a Nasdaq-100 mirror....
24/7 Wall Street - 5/31/2026 6:41:50 AM
More News for CHAT
Stock Analysis for CHAT
Related Stocks:
Get up to 24 months with 0% intro APR on this week's top offers. Stop losing money to interest and start making real headway on your balance....
Fool - Investing News - 5/31/2026 6:32:34 AM
More News for
Stock Analysis for
Related Stocks:
This high-yield savings account is offering a strong 4.10% APY for your first six months when you use a promo code. Here's what to know and how to earn it today....
Fool - Investing News - 5/31/2026 6:32:33 AM
More News for
Stock Analysis for
Related Stocks:
Here's a practical framework for deciding if a credit card's annual fee pays off, plus a personal take on running the real math before applying....
Fool - Investing News - 5/31/2026 6:32:31 AM
More News for
Stock Analysis for
Related Stocks:
This stock gives you exposure to growth in artificial intelligence (AI), space, and more....
Fool - Investing News - 5/31/2026 6:15:00 AM
More News for AMZN
Stock Analysis for AMZN
Related Stocks:
This has only been witnessed one other time since the early 1870s....
Fool - Investing News - 5/31/2026 6:06:00 AM
More News for
Stock Analysis for
Related Stocks:
Nvidia stock has pulled back followings its Q1 report. What comes next?...
Fool - Investing News - 5/31/2026 5:45:00 AM
More News for NVDA
Stock Analysis for NVDA
Related Stocks:
The NTSB said it appeared that a high rate of speed played a role in a bus crashing into six vehicles Friday on Interstate 95 in Virginia, killing five and injuring dozens....
WTOP - 5/30/2026 10:36:06 PM
More News for
Stock Analysis for
Related Stocks:
Morgan Wallen's song "180" might as well have described his piano last night ... because he nearly flipped the thing completely over mid-show!...
TMZ - 5/30/2026 10:30:14 PM
More News for
Stock Analysis for
Related Stocks:
Authorities halted their investigation due to "dangerous river conditions" and to focus their efforts after Brown's brother said he fears he is dead....
Yahoo - 5/30/2026 10:24:51 PM
More News for
Stock Analysis for
Related Stocks:
Molson Coors Beverage Company is upgraded to Strong Buy, as the valuation disconnect widens despite solid fundamentals and recovery potential. TAP maintains robust cash flow and a healthy balance sheet and offers a potential double-digit combined dividend-plus-buyback yield, which is covered by the underlying free cash flow. Management targets $450 million in cost savings by 2029, network modernization, and premiumization to offset macro and competitive pressures....
Seeking Alpha - 5/31/2026 6:25:16 AM
More News for TAP
Stock Analysis for TAP
Related Stocks:
Higher inflation, oil volatility, and mixed growth signals keep the Fed under pressure as markets price a higher-for-longer interest rate outlook, with Treasury yields, the U.S. dollar, and major stock indices reacting to shifting rate expectations....
FXEmpire - 5/31/2026 6:16:23 AM
More News for DOW
Stock Analysis for DOW
Related Stocks:
Alcon receives a buy rating, driven by the launch of Tryptyr in the mature dry eye disease market. Tryptyr's unique mechanism and rapid tear production differentiate it, but commercial adoption hinges on refill rates, payer coverage, and patient persistence. ALC's robust commercial footprint and strong balance sheet support ongoing R&D, M&A, dividends, and buybacks, mitigating financing risks....
Seeking Alpha - 5/31/2026 6:11:04 AM
More News for ALC
Stock Analysis for ALC
Related Stocks:
Nokia OyjJohtohenkilöiden liiketoimet31. 5. 2026 klo 13. 00Nokia Oyj - Johtohenkilöiden liiketoimet (Hanrahan) Markkinoiden väärinkäyttöasetuksen 19. artiklan mukainen ilmoitus liiketoimesta....
Globe News Wire - 5/31/2026 6:00:00 AM
More News for
Stock Analysis for
Related Stocks:
Nokia CorporationManagers' transactions31 May 2026 at 13:00 EESTNokia Corporation - Managers' transactions (Hanrahan) Transaction notification under Article 19 of EU Market Abuse Regulation. ____________________________________________Person subject to the notification requirementName: Hanrahan, VictoriaPosition: Other senior manager Issuer: Nokia CorporationLEI: 549300A0JPRWG1KI7U06Notification type: INITIAL NOTIFICATIONReference number: 158758/5/6____________________________________________Transaction date: 2026-05-26Venue: XNYSInstrument type: SHAREISIN: US6549022043Nature of the transaction: ACQUISITION Transaction details(1): Volume: 22713 Unit price: 16....
Globe News Wire - 5/31/2026 6:00:00 AM
More News for
Stock Analysis for
Related Stocks:
Disney will host the Super Bowl, the Oscars and the Grammys in 2027, all of which are major drivers of advertising revenue. Global advertising chief Rita Ferro has been leading the charge and is in the midst of upfront negotiations with advertisers....
CNBC - 5/31/2026 6:00:01 AM
More News for FOE
Stock Analysis for FOE
Related Stocks:
InterContinental Hotels Group delivered accelerating 1Q26 RevPAR growth, beating consensus and supporting a positive operational outlook. IHG's pipeline is increasingly weighted toward luxury and premium properties, driving higher fee revenue and margin expansion. Despite macro concerns, IHG sees no US demand slowdown; robust cash generation supports strong dividend growth and buybacks....
Seeking Alpha - 5/31/2026 5:59:27 AM
More News for IHG
Stock Analysis for IHG
Related Stocks:
Follow along for all the top moments and highlights from Game 7 between the Oklahoma City Thunder and San Antonio Spurs....
ESPN - 5/30/2026 9:54:59 PM
More News for
Stock Analysis for
Related Stocks:
A family of four from Massachusetts who were killed when a bus crashed into multiple vehicles in Virginia were traveling to a wedding at the time....
AP News - 5/30/2026 9:53:00 PM
More News for
Stock Analysis for
Related Stocks:
Spotify, the streaming giant, has added more than 650 narrated articles to its audiobook library. It is pulling in stories from major publications, including Spotify, Rolling Stone, WIRED, The Atlantic, Variety and Pitchfork....
Forbes - 5/31/2026 5:51:05 AM
More News for SPOT
Stock Analysis for SPOT
Related Stocks:
American Express and Visa operate different business models, with the former capturing all the economics of a transaction. Visa's capital-light setup supports substantial profits and capital returns, but its valuation is higher....
The Motley Fool - 5/31/2026 5:15:00 AM
More News for EXPRQ
Stock Analysis for EXPRQ
Related Stocks:
A loud boom was reported across eastern Massachusetts. Police report no damage reports. NBC10 meteorologist says it could be a meteor or bolide....
NBC Boston - 5/30/2026 9:37:00 PM
More News for
Stock Analysis for
Related Stocks:
Booz Allen Hamilton is a market-leading government consulting firm, currently trading at a significant discount to historical valuation multiples. BAH boasts a 14-year dividend growth streak, strong dividend safety, and the highest yield in a decade, supporting its status as a long-term dividend growth play. Recent headwinds from government unpredictability and contract losses have stabilized, with defense and intelligence segments showing resilience and civil business signaling some recovery....
Seeking Alpha - 5/31/2026 5:36:37 AM
More News for BAH
Stock Analysis for BAH
Related Stocks:
The S&P 500 is considered the best benchmark for the overall U.S. stock market. Excluding dividends, the S&P 500 returned 9.3% annually over the last 20 years....
The Motley Fool - 5/31/2026 5:12:00 AM
More News for IVV
Stock Analysis for IVV
Related Stocks:
Wondering how high next year's Social Security benefit increase will be? Pay attention to the American consumer....
Fool - Investing News - 5/31/2026 5:10:00 AM
More News for PIPR
Stock Analysis for PIPR
Related Stocks:
Micron joins players including Nvidia and Microsoft in this exclusive group....
Fool - Investing News - 5/31/2026 5:05:00 AM
More News for MU
Stock Analysis for MU
Related Stocks:
The Latin American digital bank is aiming to enter the US. market....
Fool - Investing News - 5/31/2026 5:00:00 AM
More News for NU
Stock Analysis for NU
Related Stocks:
Alphabet is ramping up efforts to compete with Nvidia in the market for AI accelerators....
Fool - Investing News - 5/31/2026 4:48:00 AM
More News for GOOGL
Stock Analysis for GOOGL
Related Stocks:
A United Airlines flight bound for Minneapolis was diverted to Wisconsin on Friday night after reports of an unruly passenger....
AP News - 5/30/2026 9:34:00 PM
More News for
Stock Analysis for
Related Stocks:
The fund has sparked a broad backlash since it was announced earlier this month, exposing fractures within the Republican Party....
NPR - 5/30/2026 9:32:28 PM
More News for
Stock Analysis for
Related Stocks:
Hours after Cooper's decision, Trump said he was backing away from the renovations and making arrangements to relinquish control to Congress....
Fortune - 5/30/2026 8:49:00 PM
More News for
Stock Analysis for
Related Stocks:
Jeff Bezos and Elon Musk both faced challenges this past week in the race to make their sci-fi dreams a reality....
WSJ - 5/31/2026 5:30:00 AM
More News for EMLAF
Stock Analysis for EMLAF
Related Stocks:
